Phase 3 data support “changing the current standard of care to now include neoadjuvant and adjuvant pembrolizumab,” according to Ravindra Uppaluri, MD, PhD.

In India, cancers of the head and neck mdash;including those affecting the oral cavity, voice box, throat, nasal passages, and salivary glands mdash;represent a major health challenge, even if they ...

Head and neck cancers, encompassing growths in the throat, larynx, nose, and mouth, account for 4% of cancers worldwide. Key ...

Talking to loved ones about a recent head and neck cancer diagnosis can be overwhelming. Of course, there is no one "right" ...

Proper nutrition is important for people diagnosed with cancer, both to help them feel better and to assist them in ...

Head and neck cancers are among the most difficult to treat. They can be aggressive and are located near some of the body's ...

A new review was published in Volume 16 of Oncotarget on June 25, 2025, titled "Challenges and resistance mechanisms to EGFR ...

Addition of neoadjuvant and adjuvant pembrolizumab to standard care significantly improves event-free survival.

The European Commission (EC) has approved BeOne Medicines’ Tevimbra (tislelizumab) as part of a first-line combination ...

Head and neck cancer is a term that covers a range of cancers that can have a big impact on everyday life.Here are 6 important things to know.1. What ...

Head and neck cancers arise in the nasal cavity, sinuses, lips, mouth, salivary glands, throat or larynx. As per the National ...